Social outcomes good for most pediatric brain tumor survivors

October 21, 2012
Social outcomes good for most pediatric brain tumor survivors
While the majority of survivors of pediatric embryonal tumors display positive social outcomes several years after diagnosis and treatment, specific risk factors may affect social adjustment and behavior over the long term, according to research published online Oct. 15 in the Journal of Clinical Oncology.

(HealthDay)—While the majority of survivors of pediatric embryonal tumors display positive social outcomes several years after diagnosis and treatment, specific risk factors may affect social adjustment and behavior over the long term, according to research published online Oct. 15 in the Journal of Clinical Oncology.

Tara M. Brinkman, Ph.D., of the St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues conducted a five-year, prospective, longitudinal study involving 220 survivors of pediatric embryonal tumors to evaluate social outcomes for these children.

The researchers found that, on measures of social functioning, few children were reported to have clinically elevated scores. Although the mean scores differed significantly from population norms, they were within the average range. Compared with patients with average-risk treatment status, children with high-risk treatment status were significantly more likely to have increased social problems and display withdrawn/depressed behavior. Over time, there were greater parent-reported social problems for those with posterior fossa syndrome. Compared with , females exhibited higher withdrawn/depressed scores over time. Parent report of social functioning also correlated with patient intelligence, age at diagnosis, and parent .

"Results of this study largely suggest positive social adjustment several years after diagnosis and treatment of a pediatric embryonal tumor," the authors write. "However, several factors, including treatment risk status and posterior fossa syndrome, may be important precursors of long-term social outcomes. Future research is needed to elucidate the trajectory of social functioning as these patients transition into adulthood."

Explore further: BMI and lean body mass decline after allogeneic HSCT

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

BMI and lean body mass decline after allogeneic HSCT

October 4, 2012
(HealthDay)—In survivors of childhood hematologic malignancies who have received allogeneic hematopoietic stem cell transplantation (alloHSCT), body mass index (BMI) decreases significantly, mainly due to a reduction in ...

Studies link depression, breast cancer outcomes

November 2, 2011
This year, more than 230,000 women will be diagnosed with breast cancer and nearly 40,000 women will not survive their battle with cancer, according to the American Cancer Society. New research from the University of Missouri ...

Health-related QoL evaluated for children with brain tumors

May 9, 2012
(HealthDay) -- In children and adolescents with brain tumors treated with proton radiation, health-related quality of life (HRQoL) scores are affected by both disease type and treatment, with assessments made by the patients ...

Six developmental trajectories ID'd in children with autism

April 2, 2012
(HealthDay) -- Six longitudinal developmental trajectories have been identified among children with autism, with significant heterogeneity seen in developmental pathways within these trajectories, according to a study published ...

Recommended for you

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

November 23, 2017
A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. The discovery ...

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

One in four U.S. seniors with cancer has had it before

November 22, 2017
(HealthDay)—For a quarter of American seniors, a cancer diagnosis signals the return of an old foe, new research shows.

Combination immunotherapy targets cancer resistance

November 22, 2017
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.